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PURPOSE. To determine whether blood pressure and subclinical
atherosclerosis are associated with incident age-related macu-
lopathy (ARM).
METHODS. The study was performed within the Rotterdam
Study, a population-based, prospective cohort study in Rotter-
dam, The Netherlands. A total of 4822 subjects who at baseline
were aged 55 years more, were free of ARM, and participated
in at least one of two follow-up examinations after a mean of 2
and 6.5 years, were included in the study. At baseline, blood
pressure and the presence of atherosclerosis were determined.
ARM was assessed according to the International Classification
and Grading System and defined as large, soft drusen with
pigmentary changes; indistinct drusen; or atrophic or neovas-
cular age-related macular degeneration.
RESULTS. After a mean follow-up of 5.2 years, incident ARM was
diagnosed in 417 subjects. Increased systolic blood pressure or
pulse pressure was associated with a higher risk of ARM.
Adjusted for age, gender, smoking, total and high-density li-
poprotein cholesterol, body mass index, and diabetes mellitus,
odds ratios (OR) per 10-mm Hg increase were 1.08 (95%
confidence interval [CI]: 1.03–1.14) and 1.11 (95% CI: 1.04–
1.18), respectively. Moreover, different measures of atheroscle-
rosis were associated with the risk of ARM. An increase in
carotid wall thickness (OR per 1 SD, 1.15; 95% CI: 1.03–1.28)
increased the risk of ARM. The lowest compared with the
highest tertile of ankle–arm index had an OR of 1.32 (95% CI:
1.00–1.75). A weak association was found between aortic
calcifications and the risk of ARM.
CONCLUSIONS. Elevated systolic blood or pulse pressure or the
presence of atherosclerosis may increase the risk of develop-
ment of ARM. (Invest Ophthalmol Vis Sci. 2003;44:3771–3777)
DOI:10.1167/iovs.03-0121
In a recent report, the National Eye Institute estimated thatcurrently 1.6 million Americans have from age-related mac-
ular degeneration (AMD), the most common cause of incurable
blindness and visual impairment in industrialized countries.1,2
Because of the aging of the population, the institute expects
this number to double over the next 30 years. At this moment,
treatment options include thermal laser and photodynamic
therapy, but they are effective in a minority of patients only.3,4
Prevention of AMD is hampered by a lack of knowledge about
etiology and modifiable risk factors.5 Only high-dose supple-
mentation with specific antioxidant nutrients has been shown
to slow the development of AMD.6
Decades ago, in 1937, Verhoeff and Grossman postulated
that systemic vascular factors may be involved in the patho-
genesis of AMD.7 More recently, interest in this potential rela-
tionship has grown,8 and a vascular model has been proposed
in which a process that resembles atherosclerosis causes an
accumulation of lipids and subsequently an increase in choroi-
dal vascular resistance.9 This process would interfere with the
high metabolic rate of the retinal pigment epithelium and lead
to the development of subretinal deposits (drusen), pigment
abnormalities, and, finally, the blinding late stages of atrophic
or neovascular AMD. Collectively, these early and late fundus
signs are called age-related maculopathy (ARM), according to
an international consensus.10
Most epidemiologic studies have addressed the vascular
hypothesis by studying the classic risk factors for cardiovascu-
lar disease, such as blood pressure, serum cholesterol, and
smoking, as well as clinical manifestations of atherosclerosis,
such as myocardial infarction. Except for smoking, the results
have been inconclusive.11–20 However, very few of these stud-
ies were population based and prospective in design. Only two
prevalence studies, including a cross-sectional analysis of the
Rotterdam Study, used direct measurements of atherosclero-
sis.21,22
To explore further the vascular hypothesis, we studied, in a
population-based cohort, the association of systemic blood
pressure and subclinical atherosclerosis with the risk of ARM.
We used noninvasive techniques for the measurement of ath-




Information on the identification and description of the baseline study
population has appeared in previous reports.23 Briefly, the Rotterdam
Study is a population-based prospective cohort study of the frequency
and determinants of common cardiovascular, locomotor, neurologic,
and ocular diseases.24 The eligible population (n  10,275) consisted
of all inhabitants aged 55 years or more in a suburb of Rotterdam, The
Netherlands. Of these, 7983 (78%) subjects agreed to participate in the
study. Because the ophthalmic part of the study became operational
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after the screening of participants had started, a smaller portion (n 
6780) participated in the ophthalmic examination. The study was
conducted according to the tenets of the Declaration of Helsinki, and
the medical ethics committee of the Erasmus Medical Center approved
the study protocol. Written informed consent was obtained from all
participants. Baseline interviews and examinations were performed
from 1990 to mid-1993, followed by a first follow-up examination from
1993 to 1994. A second follow-up screening took place from mid-1997
to the end of 1999.
Diagnosis of Age-Related Maculopathy
A detailed description of the diagnostic procedures has been presented
elsewhere.23 Participants underwent a full eye examination, including
stereo 35° fundus photography (TRV-50VT fundus camera; Topcon
Optical Corp., Tokyo, Japan) centered on field 2 (the fovea) after
pharmacologic mydriasis. The resultant transparencies were graded
with 12.5 magnification, according to the International Classification
and Grading System for ARM and AMD.10 In this system, all ARM
fundus signs within a standard circular area (diameter 6000 m)
around the fovea are recorded. Two graders, trained according to the
Wisconsin ARM grading system and having 8 years experience, first
graded the follow-up transparencies, after which the grades were
compared with grades of those taken at baseline. The grading proce-
dures and definitions, as well as the graders, were identical at baseline
and at follow-up. Consensus sessions were conducted, and between-
grader comparisons were performed regularly. Weighted  statistics
were 0.72 for soft distinct drusen, 0.80 for hyperpigmentation, and
0.58 for hypopigmentation.
ARM was defined as the presence of large (63 m), soft, distinct
drusen with pigmentary irregularities, or indistinct (125 m) or
reticular drusen, or atrophic or neovascular AMD. Atrophic AMD was
defined as any sharply demarcated round or oval area of apparent
absence of the RPE, larger than 175 m, irrespective of distance from
the foveola but within the grid, with visible choroidal vessels and no
neovascular AMD. Neovascular AMD was defined as the presence of a
serous or hemorrhagic neuroretinal or RPE detachment, and/or a
subretinal neovascular membrane, and/or a subretinal hemorrhage,
and/or a periretinal fibrous scar. Lesions that were considered to be the
result of generalized disease, such as diabetic retinopathy, chorioreti-
nitis, high myopia, trauma, congenital diseases, or photocoagulation
for reasons other than for neovascular AMD, were excluded from ARM
diagnosis.
Exposure Measurement
Information on smoking habits and current use of medication was
derived from the baseline interview. Smoking was categorized as
never, former, or current. At the research center, height and weight
were determined, and nonfasting blood samples were obtained. Serum
total cholesterol and HDL-cholesterol levels were measured by an
automated enzymatic procedure. Diabetes mellitus was considered to
be present when subjects currently used oral blood-glucose–lowering
medication or insulin, or had a nonfasting or postload glucose level
above 11.0 mM.
Blood pressure was measured with a random-zero sphygmomanom-
eter at the right brachial artery with the subject in a sitting position,
and two consecutive measurements were averaged. Pulse pressure was
calculated by taking the difference between systolic and diastolic
blood pressure. The systolic blood pressure level of the posterior tibial
artery was measured at both sides using an 8-MHz continuous-wave
Doppler probe (500 D; Huntleigh, Sussex, UK) and a random-zero
sphygmomanometer. The ankle–arm index was calculated by taking
the ratio of the systolic blood pressure at the ankle to the systolic
pressure at the arm. The ratio was calculated for each leg, and the
lowest index was used in the analyses. An ankle–arm index 0.90 was
considered to indicate peripheral atherosclerosis.
The wall thickness of the carotid artery was assessed by ultrasonog-
raphy using a 7.5-MHz linear-array transducer (Ultra-Mark IV; ATL,
Bethel, West Australia), in accordance with the Rotterdam Study ultra-
sound protocol.25 Briefly, the intima-media thickness was measured on
a longitudinal, two-dimensional ultrasound image of the common ca-
rotid artery, the carotid bifurcation, and the internal carotid artery at
both the left and right side. When an optimal image of the interface of
the anterior (near) and posterior (far) walls was obtained, it was frozen
on the R-wave of the electrocardiogram (ECG), stored on videotape,
and digitized by additional dedicated software. Next, the interfaces of
the common carotid artery, the carotid bifurcation, and the internal
carotid artery were marked across a length of 10 mm. The computer
calculated the mean and maximum intima-media thickness for both
near and far walls. For the analyses, the wall thickness was determined
as the mean of the maximum intima-media thickness of near- and
far-wall measurements of both the left- and right-side arteries. The
thicknesses of each of the three arterial segments were combined after
standardization. The ultrasonographers and readers of the images were
masked to the case status of the subject.
The common carotid artery, bifurcation, and internal carotid artery
were also examined for the presence of atherosclerotic plaques.
Plaques were defined as focal thickening of the vessel wall relative to
adjacent segments, composed of calcified or noncalcified components.
The plaque score reflected the total number of locations where
plaques were found, and it ranged from zero to six (left- and right-side
common carotid artery, bifurcation, and internal carotid artery).
Aortic atherosclerosis was diagnosed by detecting calcified depos-
its in the abdominal aorta on lateral radiographic films of the lumbar
spine, as described previously.26 Calcification was considered present
when linear densities were seen in an area parallel and anterior to the
lumbar spine (L1–L4). The extent of calcification was classified accord-
ing to the length of the involved area (0, 0.5 to 1, 1 to 2.5, 2.5 to
5, 5 to10, and10 cm). We considered the first classification to be
the reference; the second and third to be mild to moderate; and the
fourth, fifth, and sixth to be severe calcification.
Finally, a composite score of atherosclerosis was constructed with
both the continuous (ankle–arm index and carotid wall thickness) and
categorical measurements (number of carotid plaques and aortic cal-
cifications). To do so, we transformed all variables to a 10-point scale.
For the continuous variables, deciles were created, and subjects re-
ceived 1 point per decile. For the categorical variables, we determined
what percentage of the study population was in a less-severe category,
and this percentage was converted to points. For example, a person
with an ankle–arm index of 1.1 (6th decile), a carotid wall thickness of
0.8 mm (6th decile), carotid plaques at two locations (57% of the
population had less than two locations), and 1 cm to less than 2.5 cm
of aortic calcifications (43% had less than this), had a score of 6  6 
5.7  4.3  22.
Study Sample
Of the 6780 participants in the ophthalmic part of the baseline study,
6477 (95.5%) persons underwent fundus photography and 6418
(94.7%) persons had gradable fundus transparencies in at least one eye.
Prevalent ARM was diagnosed in 582 (9.1%) subjects, including 106
cases of AMD. This resulted in a cohort of 5836 subjects at risk who
were free of ARM (i.e., subjects with no drusen, only hard or distinct
drusen, or pigmentary abnormalities only). Of this cohort, 283 (4.8%)
subjects died before the first follow-up examination and another 789
(13.5%) subjects died before the second follow-up. Of those alive at the
first screening (n  5553), 46 subjects were lost to follow-up, 905
refused to participate, and 13 had ungradable photographs. Of those
alive at the second follow-up (n  4764), 15 subjects were lost to
follow-up, 1267 refused to participate, and 47 had ungradable photo-
graphs. In total, 4822 subjects (83% of those at risk) participated in at
least one follow-up examination. Among them, blood pressure mea-
surements were missing in 50 participants, ankle–arm index in 394
participants, carotid wall thickness in 770 participants, plaques in
carotid artery in 1572 participants, and aortic calcifications in 497
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participants. The main cause of missing data on ultrasonography was
restricted availability of technicians, which was irrespective of a sub-
ject’s exposure and disease status.
Incidence of ARM was defined as absence of ARM in either eye at
baseline and presence of ARM in at least one eye at follow-up.
Data Analysis
Analysis of variance, adjusted for age and gender, was used to compare
baseline characteristics of eligible subjects participating in at least one
follow-up examination with those who were alive at the time of
examination but did not participate.
We studied the associations of baseline blood pressure and athero-
sclerosis with incident ARM in subjects with no ARM at baseline.
Logistic regression analysis was used with time of follow-up included
in every model. Systolic blood pressure, diastolic blood pressure, and
pulse pressure were entered in the model, as either a continuous or
categorical variable. In the first case, the regression coefficient was
expressed per 10-mm Hg increase. In the second case, three dummy
variables were defined based on absolute blood pressures with pre-
defined cutoff points. To detect a J-shaped relationship, the second
category of diastolic blood pressure (65–74 mm Hg) was used as the
reference. Ankle–arm index was analyzed with the predefined cutoff
point of 0.9, as well as in tertiles. We studied wall thickness of the
carotid artery both as a continuous variable (per SD) and as a categor-
ical variable (tertiles). Plaques in the carotid artery were analyzed both
continuously (in number of plaques) and in categories. Aortic calcifi-
cations were studied in categories only, and the atherosclerosis com-
posite score was analyzed in quartiles.
Initially, the regression analysis was adjusted for age and gender
(model 1). In model 2, additional adjustment was made for smoking
(current, former, or never), diabetes mellitus (yes/no), total cholesterol
and HDL-cholesterol (per mM), and body mass index (kilograms per
square meter). In model 3, we also adjusted for the composite score of
atherosclerosis in the blood pressure analyses, and for systolic and
diastolic blood pressure in the atherosclerosis analyses. The associa-
tions are presented as odds ratios (ORs), which can be interpreted as
relative risks, with 95% confidence intervals (CIs). All analyses were
performed on computer (SPSS, ver. 11; SPSS Inc., Chicago, IL).
RESULTS
The baseline characteristics of the eligible study cohort, ad-
justed for age and gender, are presented in Table 1. Of the
eligible subjects who were alive at the time of follow-up ex-
amination, 1014 (17.4%) did not participate. Compared with
participants, these subjects were significantly older, included
more current smokers, more often had diabetes mellitus, used
more antihypertensive medication, and had more severe ath-
erosclerosis at baseline.
The average time between baseline and first follow-up ex-
amination was 2.0 years, and between baseline and the second
follow-up, 6.5 years. Follow-up of all participants was on aver-
age 5.2 years, with a range of 1.0 to 9.7 years (median, 6.3).
During this period, incident ARM was diagnosed in 419 sub-
jects, of whom most had early ARM and 14 had AMD (4
atrophic and 10 neovascular AMD). Incident cases of early ARM
involved large, soft drusen with pigmentary irregularities (n 
261) or indistinct drusen without (n  109) or with (n  35)
pigmentary irregularities. Incident AMD had developed in one
of the participants at the first follow-up examination and in 13
at the second. Six of these cases involved soft distinct drusen or
pigmentary abnormalities at baseline, whereas eight showed
early ARM at the first follow-up examination. The incidence of
ARM did not differ between the study sample and participants
with missing data on atherosclerosis (P 0.17, adjusted for age
and gender).
In Table 2, the odds ratios (OR) of incident ARM associated
with baseline blood pressure are shown. When adjusted for age
and gender, elevated systolic blood pressure was associated
with an increased risk of ARM (OR per 10-mm Hg increase:
1.06, 95% CI: 1.01–1.12). When additional adjustments were
made for smoking, total and HDL cholesterol, body mass index,
diabetes mellitus, and the composite score of atherosclerosis,
the association remained statistically significant. Diastolic





Age (y) 67.1  0.1 73.9  0.3†
Female (%) 59.1  0.01 59.0  0.02
Body mass index (kg/m2) 26.4  0.1 26.1  0.1‡
Smoking (%)
Never 35.2  0.01 30.5  0.01†
Former 43.3  0.01 38.6  0.02†
Current 21.6  0.01 30.9  0.01†
Diabetes mellitus (%) 9.8  0.4 13.5  1.0†
Mean total cholesterol (mM) 6.67  0.02 6.56  0.04‡
Mean HDL cholesterol (mM) 1.35  0.01 1.34  0.01
Systolic blood pressure (mm Hg) 138.6  0.3 140.4  0.7‡
Diastolic blood pressure (mm Hg) 73.8  0.2 74.1  0.4
Antihypertensive medication (%) 30.9  0.01 34.7  0.02‡
Ankle–arm index 1.08  0.003 1.02  0.007†
Wall thickness common carotid artery (mm) 0.79  0.002 0.81  0.005†
Carotid plaques (%)
0 plaques 40.9  0.01 40.1  0.02
1–3 plaques 44.7  0.01 38.7  0.02†
4–6 plaques 14.4  0.01 21.2  0.02†
Atherosclerosis composite score 26.2  0.02 28.4  0.04†
Values are age-adjusted means or percentages  SE.
* Not participating, but alive at the moment of screening.
† P  0.01.
‡ P  0.05.
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blood pressure was also associated with ARM, but this did not
reach statistical significance (OR per 10-mm Hg increase: 1.05,
95% CI: 0.96–1.15, adjusted for age and gender). Additional
adjustment did not change this relationship. Also, taking the
lowest category as reference instead of the second did not
change the risk estimates. Pulse pressure was positively asso-
ciated with the risk of ARM, both as a continuous and as a
categorical variable. Adjustment for the composite score of
atherosclerosis, however, attenuated the association with cat-
egories of pulse pressure to nonsignificant levels. Excluding
subjects who used blood pressure-lowering medication at base-
line did not substantially alter the results (data not shown).
Table 3 presents the association between ankle–arm index
and risk of ARM. Peripheral atherosclerosis was not associated
with ARM. However, when the ankle–arm index was analyzed
in tertiles, the lowest compared with the highest tertile
showed a borderline significantly increased risk of ARM (OR:
1.32, 95% CI: 1.00–1.75). The association was a little stronger
when additional adjustments were made, but became nonsig-
nificant when adjusted for systolic and diastolic blood pres-
sure.
Table 4 shows the relationship between measures of ath-
erosclerosis in the carotid artery and risk of ARM. Increased
wall thickness of the common carotid artery, both as a contin-
uous (per standard deviation) and as a categorical variable,
significantly increased the risk of ARM. Per SD (0.15 mm) of
wall thickness, the OR was 1.15 (95% CI: 1.03–1.29; adjusted
for age and gender). The highest tertile of carotid wall thick-
ness compared with the lowest tertile had an OR of 1.45 (95%
CI: 1.07–1.97). Additional adjustment for cardiovascular risk
factors (model 2), including systolic and diastolic blood pres-
sure (model 3) did not substantially alter the results. Plaques in
the carotid artery were also associated with an increased risk of
ARM. Compared with no plaques, four to six plaques in the
right and left carotid artery increased the risk of ARM nearly
50% (OR: 1.46, 95% CI: 1.02–2.09, adjusted for age and gen-
der). Additional adjustment for systolic and diastolic blood
pressure decreased this risk estimate to a slight extent.
The relation between calcification of the abdominal aorta
and ARM is shown in Table 5. A positive but not statistically
significant association was found between aortic calcification
and the incidence of ARM. Adjusted for all potential confound-
ers, severe calcifications compared with none carried an OR of
1.39 (95% CI: 0.98–1.98).
Finally, in Table 6, the analysis of the composite score of
atherosclerosis is presented. The highest score compared with
the lowest carried an OR of 1.53 (95% CI: 1.08–2.18). Addi-
tional adjustment for cardiovascular risk factors only marginally
TABLE 2. Adjusted ORs of Incident ARM Associated with Baseline Blood Pressures
Subjects (n) Cases (n)
Adjusted OR (95% CI)
Model 1* Model 2† Model 3‡
Systolic BP (per 10-mm Hg increase) 4772 416 1.06 (1.01–1.12) 1.08 (1.03–1.14) 1.07 (1.01–1.13)
Systolic BP categories (mm Hg)
120 977 52 1.00 1.00 1.00
120–139 1689 143 1.47 (1.06–2.05) 1.61 (1.14–2.27) 1.63 (1.12–2.37)
140–159 1366 140 1.70 (1.22–2.39) 1.86 (1.31–2.66) 1.81 (1.23–2.67)
160 740 81 1.85 (1.27–2.69) 2.07 (1.40–3.07) 2.08 (1.36–3.20)
Diastolic BP (per 10-mm Hg increase) 4772 416 1.05 (0.96–1.15) 1.07 (0.97–1.17) 1.07 (0.97–1.18)
Diastolic BP, categories (mm Hg)
65 940 86 1.05 (0.79–1.39) 1.03 (0.77–1.38) 0.92 (0.67–1.27)
65–74 1675 144 1.00 1.00 1.00
75–84 1367 114 1.02 (0.79–1.32) 1.04 (0.80–1.36) 0.97 (0.73–1.29)
85 790 72 1.23 (0.91–1.67) 1.27 (0.93–1.73) 1.23 (0.88–1.71)
Pulse pressure (per 10-mm Hg increase) 4772 416 1.09 (1.02–1.15) 1.11 (1.04–1.18) 1.08 (1.00–1.16)
Pulse pressure, categories (mm Hg)
50 1013 54 1.00 1.00 1.00
50–64 1610 140 1.45 (1.04–2.02) 1.50 (1.07–2.11) 1.26 (0.88–1.81)
65–79 1309 129 1.51 (1.07–2.12) 1.54 (1.08–2.19) 1.41 (0.97–2.06)
 80 840 93 1.59 (1.09–2.30) 1.73 (1.18–2.54) 1.41 (0.92–2.15)
* Adjusted for age and gender.
† Additional adjustment for smoking, total and HDL cholesterol, body mass index, and diabetes mellitus.
‡ Additional adjustment for a composite score of atherosclerosis (see text).
TABLE 3. Adjusted ORs of ARM Associated with Ankle–Arm Index
Subjects (n) Cases (n)
Adjusted OR (95% CI)
Model 1* Model 2† Model 3‡
Ankle–arm index, categories
0.9 3833 326 1.00 1.00 1.00
0.9 595 54 0.90 (0.66–1.24) 0.90 (0.64–1.25) 0.81 (0.52–1.27)
Ankle-arm index, tertiles
1st (highest) 1604 118 1.00 1.00 1.00
2nd 1560 133 1.17 (0.90–1.52) 1.17 (0.89–1.54) 1.10 (0.83–1.45)
3rd (lowest) 1264 129 1.32 (1.00–1.75) 1.39 (1.04–1.84) 1.26 (0.94–1.69)
*,† For adjustments in models, see Table 2.
‡ Additional adjustment for systolic and diastolic blood pressure.
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reduced this risk estimate, but adjustment for blood pressure
made it nonsignificant (OR: 1.41, 95% CI: 0.95–2.09).
DISCUSSION
In this prospective cohort study, we observed that high sys-
tolic blood pressure or high pulse pressure and the presence of
atherosclerosis were associated with an increased risk of ARM.
The association was overall not altered when adjusted for
confounders and was strongest for atherosclerosis in the ca-
rotid artery.
In this study, we used the combination of early and late
signs of ARM as incident outcome. Because subjects with early
stages at baseline were excluded, AMD developed in very few
(n  14) within the 5-year follow-up period and the large
majority (97%) of incident cases were of early ARM. When
participants with incident AMD were excluded from the anal-
ysis, the same results were obtained (data not shown). We may
therefore conclude that blood pressure and atherosclerosis
promote the development of drusen and other signs of early
ARM and not (only) the progression of early ARM to neovas-
cular AMD, as has been suggested by some investigators.27 A
separate analysis of those cases of only neovascular AMD as an
outcome was not possible because of the small sample. Given
the well-documented risk of early ARM to progress to the
blinding stage of AMD, it seems justified to assume that risk
factors of early ARM also increase the risk of AMD.28,29
A concern in this as well as other follow-up studies is
selective nonresponse. Because the international standard for
the diagnosis of ARM in epidemiologic studies relies on fundus
photography,10 follow-up depends on a subject’s participation
in the eye examination. According to the analysis of baseline
characteristics, subjects who did not participate in the fol-
low-up examinations had more cardiovascular risk factors and
more atherosclerosis. Therefore, subjects with severe athero-
sclerosis were underrepresented in the studied sample. This
reduction in the range of atherosclerosis severity made it more
difficult to find an association.
Sixteen percent of participants had missing data on carotid
wall thickness and plaques, which was mainly due to logistic
problems and to technical difficulties in visualization of the
carotid artery. Because these reasons were not related to ca-
rotid wall thickness, we do not think that this biased our
results. Still, it is possible that some error occurred in the
measurement of atherosclerosis. Such a measurement error
would have led to an underestimation of the true relationship
with ARM, provided that the error occurred to the same extent
among subjects with ARM and those without. Another ques-
tion to be discussed is whether ankle–arm index and ultrasono-
graphic measurement of carotid wall thickness are true indica-
tors of atherosclerosis. The relation between ankle–arm index
and atherosclerosis seems well established.30 Increase in the
carotid intima-media thickness may also reflect hypertrophy of
the vessel wall as a response to hypertensive stress. Because
many studies have shown that increased carotid wall thickness
is associated independently of hypertension with both cardio-
vascular risk factors and cardiovascular events, it can be re-
garded as a valid indicator of atherosclerosis.25,31
An association between blood pressure or hypertension and
prevalent AMD was reported earlier in three case–control
studies: the Eye Disease Case–Control Study,12 the AMD Risk
Factors Study,15 and the Age-Related Eye Disease Study.14 Also,
the Framingham Eye Study found an association between prev-
alent ARM and hypertension diagnosed 25 years before.11 On
the contrary, no association between blood pressure and prev-
alence of ARM was found in several population-based stud-
ies.16–21 The only prospective, population-based study of this
association so far, the Beaver Dam Eye Study, found that both
systolic blood pressure and hypertension were significantly
related to the incidence of retinal pigment epithelial depigmen-
tation, but not of drusen.13 Loss of power may be the expla-
TABLE 4. Adjusted ORs of ARM Associated with Carotid Artery Wall Thickness and Presence of Plaques
Subjects (n) Cases (n)
Adjusted OR (95% CI)
Model 1* Model 2† Model 3‡
Wall thickness carotid artery, per SD 4052 357 1.15 (1.03–1.28) 1.15 (1.03–1.29) 1.11 (0.99–1.25)
Wall thickness carotid artery, tertiles
1st 1489 94 1.00 1.00 1.00
2nd 1381 127 1.26(0.95–1.68) 1.33 (0.99–1.79) 1.30 (0.96–1.75)
3rd 1182 136 1.45(1.07–1.97) 1.53 (1.12–2.11) 1.42 (1.03–1.97)
Plaques in carotid artery, per plaque 3250 290 1.06 (0.98–1.14) 1.06 (0.98–1.15) 1.04 (0.96–1.13)
Plaques in carotid artery, categories
0 1377 107 1.00 1.00 1.00
1–3 1429 127 1.02 (0.77–1.34) 1.02 (0.77–1.35) 0.97 (0.72–1.29)
4–6 444 56 1.46 (1.02–2.09) 1.49 (1.03–2.17) 1.36 (0.93–1.99)
*,†,‡ For adjustments in models, see Table 3.
TABLE 5. Adjusted ORs of ARM Associated with Aortic Calcifications
Subjects (n) Cases (n)
Adjusted OR (95% CI)
Model 1* Model 2† Model 3‡
Aortic calcification, categories
No 1556 85 1.00 1.00 1.00
Mild to moderate 1574 127 1.24 (0.93–1.66) 1.24 (0.92–1.68) 1.36 (0.98–1.88)
Severe 1195 108 1.23 (0.90–1.68) 1.28 (0.92–1.76) 1.39 (0.98–1.98)
*,†,‡ For adjustments in models, see Table 3.
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nation, because the number of incident cases of early ARM in
their cohort was about half that in our study.
The association between ultrasonographically determined
atherosclerosis, and the incidence of ARM has not yet been
studied, as far as we know. Klein et al.21 have studied the
prevalence of ARM in the population-based Atherosclerosis
Risk in Communities (ARIC) study, in which data on carotid
intima-media wall thickness and carotid plaques were available.
They found a statistically significant association between ca-
rotid plaques and retinal depigmentation, but, referring to the
large number of associations studied, they concluded that ath-
erosclerosis was unrelated to ARM overall. Also, they used
nonstereoscopic 45° fundus photographs taken through a non-
pharmacologically dilated pupil of only one eye, which may
have resulted in a decreased detection of ARM.32 In an earlier
cross-sectional analysis of data from the Rotterdam Study, we
found that subjects with plaques in the carotid bifurcation
were 4.5 times more likely to have AMD.22 Also, an ankle–arm
index below 0.9 was significantly (OR: 2.0; 95% CI: 1.2–3.2)
associated with the presence of AMD. However, in the latter
study, the early signs of ARM were not included, and the
number of AMD cases were low with corresponding wide
confidence intervals. Moreover, given the cross-sectional de-
sign no causal inferences could be made.
Not all measures of atherosclerosis yielded the same results.
The strongest association with ARM was observed for carotid
wall thickness and carotid plaques, whereas no association was
found for calcifications in the abdominal aorta and peripheral
arterial disease. Considering this difference, one might hypoth-
esize that atherosclerosis of the cerebral circulation is more
important for the risk of ARM than atherosclerosis of the aorta
or peripheral arteries.
There are several ways in which atherosclerosis may be
related to ARM. Carotid atherosclerosis may lead to stenosis
and, in the end, to a diminished blood flow to the ophthalmic
artery and in the choroidal and retinal circulation. Considering
the low prevalence of carotid stenosis in our cohort, this
explanation seems implausible. It is more likely that the ath-
erosclerosis we measured reflects a similar process in the
choroidal vessels under the retina. Thickening and stiffening of
the vessel wall results in a decreased lumen diameter, an
increased blood flow resistance, and a decreased tissue perfu-
sion. This process may then either directly impair the function-
ing of the retinal pigment epithelium, which is responsible for
the metabolism of rod and cone outer segments, or may lead to
leakage and deposition of proteins and lipids due to elevated
hydrostatic pressure, as was proposed by Friedman.9 A de-
creased choriocapillary density was demonstrated in aging hu-
man eyes, especially in those with ARM.33 Moreover, in pa-
tients with ARM, reduced choroidal perfusion was shown by
direct measurement of the choroidal blood flow.34–37 In sum-
mary, multiple lines of evidence suggest a role for atheroscle-
rosis in the pathophysiology of ARM.
The question should be answered of whether high blood
pressure is a risk factor for ARM in itself or high blood pressure
is a risk factor for ARM only through its association with
atherosclerosis. To disentangle this relationship, we put both
determinants in the same model. Adjustment for the composite
score of atherosclerosis did not change the association be-
tween systolic or diastolic blood pressure and ARM. The asso-
ciation with pulse pressure was somewhat attenuated, possibly
indicating that pulse pressure has more overlap with athero-
sclerosis. Additional adjustment for systolic and diastolic blood
pressure altered only to a slight degree the risk estimates for
the association of atherosclerosis with ARM. The interpretation
of these analyses may be that high blood pressure and athero-
sclerosis, independent of each other, increase the risk of ARM.
However, because both determinants are strongly linked and
both were measured at the same time, the previous analyses
are not sufficient to determine the exact order of the patho-
physiological pathway.
The level of oxidative defense could disturb the association
between atherosclerosis and ARM. Because oxidative stress is
implicated both in the etiology of ARM38 and in the pathogen-
esis of atherosclerosis,39 antioxidants may act as a confounder
in the observed association. However, this confounder is less
likely to explain the relationship between blood pressure and
ARM, which was independent of atherosclerosis.
In conclusion, in this large prospective cohort study we
showed that high systolic blood pressure, high pulse pressure,
or the presence of subclinical atherosclerosis increases the risk
of ARM. The magnitude of the risk estimates varied, with a
maximum OR of 2.1. Because of the high prevalence of hyper-
tension and atherosclerosis in the population, the impact of
these factors on the total incidence of ARM may still be large.
Our results suggest that a reduction in the occurrence of
hypertension and atherosclerosis may add to the prevention of
this blinding disease.
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